Business

Premier Biomedical Pain Management Solutions Executives Advance Plans for an Array of Opioid-Free New Products to Compete in $112 Billion Global Pain Market Beginning January 2017

Premier Biomedical Pain Management Solutions Executives Advance Plans for an Array of Opioid-Free New Products to Compete in $112 Billion Global Pain Market Beginning January 2017.

articlePremier Biomedical IncNovember 9, 20164/company/premier-biomedical-inc/news/premier-biomedical-pain-management-solutions-executives-advance-plans-for-an-array-of-opioid-free-new-products-to-compete-in-dollar112-billion-global-pain-market-beginning-january-2017
Premier Biomedical Pain Management Solutions Executives Advance Plans for an Array of Opioid-Free New Products to Compete in $112 Billion Global Pain Market Beginning January 2017

About this update from Premier Biomedical Inc

[{"type":"text","content":"\n \n \n Premier Biomedical Pain Management Solutions Executives Advance Plans for an Array of Opioid-Free New Products to Compete in $112 Billion Global Pain Market Beginning January 2017\n \n \nPremier Biomedical Pain Management Solutions Executives Advance Plans for an Array of Opioid-Free New Products to Compete in $112 Billion Global Pain Market Beginning January 2017\n \n EL PASO, TX--(Marketwired - Nov 9, 2016) - Premier Biomedical, Inc. (OTCQB: BIEI) a biotech research public company focused on discovering, developing, and commercializing medical treatments for a wide range of diseases in humans, including innovative therapies for breast cancer as well as non-narcotic, all-natural-ingredient, 50-state legal, novel pain management therapies, announced today that the management team from their Pain Management Division will attend an upcoming cannabis business conference & expo, November 15-18, 2016 in Las Vegas. This conference is the longest running, most respected cannabis industry conference, bringing together over 7500 cannabis industry leaders and over 300 exhibitors in one place.\n William A. Hartman, President and CEO of Premier Biomedical, stated, \"This is a tremendous opportunity for us to get a better picture of this growing segment of the all-natural-ingredient pain management industry, from scouting the competition, to benchmarking competitive products and establishing key contacts with suppliers, distributors, and potential customers. The experience gathered at this conference will also assist us in our on-going efforts to launch products to compete in the $112 billion global pain management market. Our initial product sales are slated to begin in just a few weeks, in January, 2017, with continuing multiple product launches throughout 2017. The products we will be launching include a 96-hour pain patch versus the competition at 6-12 hours, roll-ons, creams, sprays, lip balms and capsules.\"\n Ronald T. LaBorde, Managing Director of Premier's Pain Management Solutions Joint Venture, said, \"This is the premier event in the cannabis industry. Every serious player in the industry from growers, to manufacturers, to investors, to distributors and customers attend this event -- a veritable Who's Who of the industry. This conference comes at exactly the right time for us, as we are ...

More updates from Premier Biomedical Inc